UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 420

Sortiert nach

Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV

Drug design, development and therapy, 2015-01, Vol.9 (default), p.3547-3555

2015

Link zum Volltext

Verfügbarkeit prüfen

Deciphering the serological response to syphilis treatment in men living with HIV

AIDS (London), 2020-11, Vol.34 (14), p.2089-2096

2020

Link zum Volltext

Verfügbarkeit prüfen

Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease

BMC infectious diseases, 2022-12, Vol.22 (1), p.928-928

2022

Link zum Volltext

Verfügbarkeit prüfen

Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?

The Journal of infectious diseases, 2020-03, Vol.221 (8), p.1219-1222

2020

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

The New England journal of medicine, 2013-11, Vol.369 (19), p.1807-1818

2013

Link zum Volltext

Verfügbarkeit prüfen

Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression

PloS one, 2021-07, Vol.16 (7), p.e0254149-e0254149

2021

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Clinical infectious diseases, 2021-03, Vol.72 (6), p.1064-1066

2021

Link zum Volltext

Verfügbarkeit prüfen

Pilot study assessing the Rotterdam Healthy Aging Score in a cohort of HIV-positive adults in Toronto, Canada

AIDS (London), 2020-05, Vol.34 (6), p.859-867

2020

Link zum Volltext

Verfügbarkeit prüfen

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Clinical infectious diseases, 2016-04, Vol.62 (7), p.919-926

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction

The Journal of infectious diseases, 2015-01, Vol.211 (1), p.10-18

2015

Link zum Volltext

Verfügbarkeit prüfen

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

The Lancet (British edition), 2011-07, Vol.378 (9787), p.238-246

2011

Link zum Volltext

Verfügbarkeit prüfen

A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection

PloS one, 2022-07, Vol.17 (7), p.e0270590-e0270590

2022

Link zum Volltext

Verfügbarkeit prüfen

Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study

PloS one, 2009-12, Vol.4 (12), p.e7925-e7925

2009

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir as antiretroviral therapy in HIV/AIDS

Expert opinion on pharmacotherapy, 2014-02, Vol.15 (3), p.395-405

2014

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

PloS one, 2019-09, Vol.14 (9), p.e0221653-e0221653

2019

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.2771-2781

2016

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and In Situ Evaluation of pH-Dependence of Atazanavir Intestinal Permeability and Interactions with Acid-Reducing Agents

Pharmaceutical research, 2014-09, Vol.31 (9), p.2404-2419

2014

Link zum Volltext

Verfügbarkeit prüfen

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

PloS one, 2016-02, Vol.11 (2), p.e0148231

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines

Journal of antimicrobial chemotherapy, 2021-02, Vol.76 (3), p.729-737

2021

Link zum Volltext

Verfügbarkeit prüfen

Lymphocytic colitis in an HIV positive patient: is dolutegravir the cause?

AIDS (London), 2019-06, Vol.33 (7), p.1265-1266

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions

Pharmaceutical research, 2013-04, Vol.30 (4), p.1050-1064

2013

Link zum Volltext

Verfügbarkeit prüfen

Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs

Clinical infectious diseases, 2016-01, Vol.62 (2), p.139-147

2016

Link zum Volltext

Verfügbarkeit prüfen

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

The Lancet (British edition), 2006-08, Vol.368 (9534), p.466-475

2006

Link zum Volltext

Verfügbarkeit prüfen

Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal

AIDS (London), 2017-01, Vol.31 (1), p.175-176

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 420

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(322)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV

Deciphering the serological response to syphilis treatment in men living with HIV

Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease

Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression

Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Pilot study assessing the Rotterdam Healthy Aging Score in a cohort of HIV-positive adults in Toronto, Canada

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection

Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study

Raltegravir as antiretroviral therapy in HIV/AIDS

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition

In Vitro and In Situ Evaluation of pH-Dependence of Atazanavir Intestinal Permeability and Interactions with Acid-Reducing Agents

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

Mpox in people with past infection or a complete vaccination course: a global case series

Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines

Lymphocytic colitis in an HIV positive patient: is dolutegravir the cause?

Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions

Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs

Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal

Suchergebnisse filtern